Juan Fernando Cadavid-Vargas

Juan Fernando Cadavid-Vargas

Auto-generated profile, based on publicly available information

Juan Fernando Cadavid-Vargas

Cátedra de Bioquímica Patológica, Facultad Ciencias Exactas, Universidad Nacional de La Plata, 47 y 115, 1900, La Plata, Argentina

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2017 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
Ignacio E. LeónIgnacio E. León
Ignacio E. León
JCJuan Cadavid-Vargas
Juan Cadavid-Vargas
AVAna Di Virgilio
Ana Di Virgilio
SESusana Etcheverry
Susana Etcheverry
Cancer is a group of diseases involving abnormal cell growth. The cells grow uncontrollably with the potential to invade and spread to other parts of the body. This disease is one of the principal death causes in the world, thus becoming a significant topic of scientific research. On the other hand, transition metals play a fundamental role in different living systems. In particular, Metallodrugs represent new and powerful tools for diverse therapeutic applications. To date, various metallodrugs display interesting biological activities for chemotherapy. In this field, cisplatin was the first inorganic compound with high relevance in cancer treatment. This compound was a leader agent in clinical use. Toxicity and resistance problems trigger the development of other platinum drugs with better clinical perspective and also raise the scientific interest for the putative antitumor properties of V, Ru and Cu compounds. Several scientific articles show that complexes of these metals are the new metal-based drugs used in the treatment of several cancers, such us, lung, colon, breast, bladder, etc. In this review we recapitulate current information and new advances on antitumor in vitro effects of several organic and inorganic compounds derived from copper, ruthenium and vanadium. These metal derived compounds targeting DNA or cell proteins involved in cell signaling pathways related to cancer. The mechanisms of cell death of these metallodrugs have also been comprehensibly reviewed. The knowledge of these mechanisms of death and the relationship between chemical structure and biological activity may be useful for the design of new metal-based drugs with promising pharmacologic applications as anticancer agents.

24 September 2015 in JBIC Journal of Biological Inorganic Chemistry
Verified
Journal Article
Closed access
PDF file
Ignacio E. LeónIgnacio E. León
Ignacio E. León
JCJ. F. Cadavid-Vargas
J. F. Cadavid-Vargas
ITI. Tiscornia
I. Tiscornia
VPV. Porro
V. Porro
SCS. Castelli
S. Castelli
SES. B. Etcheverry
S. B. Etcheverry

1 October 2016 in JBIC Journal of Biological Inorganic Chemistry
Verified
Journal Article
Closed access
PDF file
Ignacio E. LeónIgnacio E. León
Ignacio E. León
JCJuan F. Cadavid-Vargas
Juan F. Cadavid-Vargas
ARAgustina Resasco
Agustina Resasco
FMFabricio Maschi
Fabricio Maschi
MAMiguel A. Ayala
Miguel A. Ayala
SESusana B. Etcheverry
Susana B. Etcheverry

1 September 2018 in Journal of Inorganic Biochemistry
Verified
Journal Article
Open access
JKJakob Kljun
Jakob Kljun
ILIgnacio E. León
Ignacio E. León
ŠPŠpela Peršič
Špela Peršič
JCJuan F. Cadavid-Vargas
Juan F. Cadavid-Vargas
SESusana B. Etcheverry
Susana B. Etcheverry
ITIztok Turel
Iztok Turel
In this study we report the synthesis, characterization and a thorough biological evaluation of twelve organoruthenium-8-hydroxyquinolinato (Ru-hq) complexes. The chosen hqH ligands bear various halogen atoms in different positions which enables to study effect of the substituents on physico-chemical and biological properties. The determined crystal structures of novel complexes expectedly show the cymene ring, a bidentately coordinated deprotonated hq and a halide ligand (chlorido or iodido) coordinated to the ruthenium central ion. In previous studies the anticancer potential of organoruthenium complex with 8-hydroxyquinoline ligand clioquinol was well established and we have decided to perform an extended biological evaluation (antibacterial and antitumor activity) of the whole series of halo-substituted analogs. Beside the cytotoxic potential of studied compounds also the effect of two selected complexes (9 and 10) on apoptosis induction in MG-63 and A549 cells was also studied via externalization of phosphatidylserine at the outer plasma membrane leaflet. Both selected complexes that gave best preliminary cytotoxicity results contain bromo substituted hq ligands. Apoptosis induction results are in agreement with the cell viability assays suggesting the higher and more selective anticancer activity of complex 10 in comparison to complex 9 on MG-63 cells.

20 February 2017 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
JCJuan Cadavid-Vargas
Juan Cadavid-Vargas
Ignacio E. LeónIgnacio E. León
Ignacio E. León
SESusana Etcheverry
Susana Etcheverry
ESEduardo Santi
Eduardo Santi
MTMaria H. Torre
Maria H. Torre
Ana Laura Di VirgilioAna Laura Di Virgilio
Ana Laura Di Virgilio
Background: Copper has shown to be useful in disorders with an inflammation origin such as cancer [1-3]. It has previously shown that Casiopeínas® interact with DNA and promote the disruption by a mechanism related to the increase in the level of free radicals [4-6] which confers antineoplastic potential. Objetive: The aim of the present work was to study the antitumor effects of a series of Cu(II) complexes with saccharinate (sac) and glutamate (gln): [Cu(sac)2(H2O)4].2H2O (Cu-sac), [Cu(gln)2] (Cu-gln) and Na2[Cu(sac)2 (gln)2].H2O (Cu-sac-gln). Methods: We have investigated the action of these compounds on cell viability on human osteosarcoma cells MG-63. In particular, we pay special attention to the cyto and genotoxicity actions of these complexes and to the association to oxidative stress. Results: The three complexes: Cu-sac, Cu-gln and Cu-sac-gln caused a decline in cell viability. The half-maximal inhibitory concentration in MG-63 cells for Cu-sac-gln is 170 µM, showing the strongest antiproliferative effect. Moreover, only Cu-sac-gln caused a decrease of the mitochondrial activity from 100 µM. Our results indicate that the copper(II) complexes studied here produce DNA damage and suggest that the rise of reactive oxygen species (ROS) is the central mechanism action. Genotoxicity studied by the Cytokinesis-block micronucleus (MN) assay and the Single cell gel electrophoresis (comet assay) could be observed in MG-63 cells treated with Cu-sac-gln from 100 and 50 µM, respectively. Cu-sac and Cu-gln also induced DNA damage; however their effect was definitively weaker. The generation of reactive oxygen species increased from 50 μM of Cu-sac-gln and Cu-sac and only from 250 µM of Cugln, as well as a reduction of the GSH/GSSG ratio from 50 µM. When cells were treated with several concentrations of the complexes in addition to a combination of 50 μM of vitamin C plus 50 µM of vitamin E, a total recovery in cell survival was obtained for Cu-gln in the whole range of tested concentrations while only a partial viability recovery was obtained from 250 µM of Cu-sac and Cu-sac-gln. Conclusion: Overall, our results point to a differential cyto- and genotoxicity of the three copper(II) complexes and demonstrate that the complexation with both ligands confers the most potent antitumor action in human osteosarcoma cells.

17 October 2018 in BioMetals
Verified
Journal Article
Closed access
PDF file
JCJuan Fernando Cadavid-Vargas
Juan Fernando Cadavid-Vargas
PAPablo Maximiliano Arnal
Pablo Maximiliano Arnal
RSRuth Dary Mojica Sepúlveda
Ruth Dary Mojica Sepúlveda
ARAndrea Rizzo
Andrea Rizzo
DSDelia Beatriz Soria
Delia Beatriz Soria
Ana Laura Di VirgilioAna Laura Di Virgilio
Ana Laura Di Virgilio